Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
7I14
- Development stage
- Preclinical
- Lead developer
- University of Toledo College of Medicine
01
Overview
7I14: sourced facts only. name: "Survivin degrader 7I14 synergizes with docetaxel in castration-resistant prostate cancer by disrupting survivin dimerization and inducing its proteasome-dependent degradation" [DOI:10.1158/1538-7445.am2025-1664]; target: "Survivin degrader 7I14 synergizes with docetaxel in castration-resistant prostate cancer by disrupting survivin dimerization and inducing its proteasome-dependent degradation" [DOI:10.1158/1538-7445.am2025-1664]; developer: "University of Toledo College of Medicine and Life Sciences, Toledo, OH." [DOI:10.1158/1538-7445.am2025-1664]; stage: "In a PC-3 xenograft model, 7I14 at 15 mg/kg administered via IP twice/week effectively suppressed tumor growth and enhanced docetaxel’s effects by degrading survivin, with no added toxicity, as assessed by body weight, white blood cell counts, and hemoglobin levels." [DOI:10.1158/1538-7445.am2025-1664]
02
Targets
BIRC5 (Survivin)
Beyond the preview
Go deeper on 7I14.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 7I14.